Merck & Co., Inc. Goodwill, Translation and Purchase Accounting Adjustments
Merck & Co., Inc. (MRK) reported Goodwill, Translation and Purchase Accounting Adjustments of -$47.00 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-25.
Financial Statements › Notes › Goodwill and Other › Goodwill, Foreign Currency Translation and Measurement Period Adjustments
us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments · last filed 2025-02-25
- Merck & Co., Inc. goodwill, translation and purchase accounting adjustments for fiscal 2024 was -$47.00M.
- Merck & Co., Inc. goodwill, translation and purchase accounting adjustments for fiscal 2023 was -$7.00M.
- Merck & Co., Inc. goodwill, translation and purchase accounting adjustments for fiscal 2022 was -$60.00M.
| Period end | Goodwill, Translation and Purchase Accounting Adjustments 12 month |
|---|---|
| 2024-12-31 | -$47.00M 10-K · filed 2025-02-25 |
| 2023-12-31 | -$7.00M 10-K · filed 2025-02-25 |
| 2022-12-31 | -$60.00M 10-K · filed 2024-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |